Breaking News Instant updates and real-time market news.

WFC

Wells Fargo

$44.76

1.01 (2.31%)

12:39
10/05/16
10/05
12:39
10/05/16
12:39

Wells Fargo suspended from Chicago business for one year, Reuters reports

Chicago's City Council approved a move to suspend Wells Fargo from doing business in the city for one year amid its fake accounts scandal, Reuters reports. The suspension includes bond underwriting, brokerage, trustee, and other services the lender has provided to the city in the past, the report notes. Reference Link

  • 23

    Oct

WFC Wells Fargo
$44.76

1.01 (2.31%)

09/22/16
DBAB
09/22/16
NO CHANGE
Target $50
DBAB
Buy
Wells Fargo price target lowered to $50 from $59 at Deutsche Bank
Deutsche Bank analyst Matt O'Connor lowered his price target for Wells Fargo to $50 saying it's "tough to argue for much upside in the near term." The analyst, however, believes that over the next year, Wells Fargo's issues should subside and its "attractive valuation should be more relevant." After laying out the bull and bear thesis on the shares, O'Connor sees 5%-12% relative upside in the name. He keeps a Buy rating on Wells Fargo.
09/28/16
DBAB
09/28/16
UPGRADE
Target $11.5
DBAB
Buy
Huntington Bancshares upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor upgraded Huntington Bancshares to Buy saying the 15% pullback in the shares since the FirstMerit (FMER) deal was announced is overdone. The analyst views industry-wide concerns surrounding consumer indirect auto lending as overblown and he raised his price target for Huntington shares to $11.50 from $10.50. Going into the Q3 results for U.S. banks, O'Connor likes JPMorgan (JPM) and Wells Fargo (WFC) and is cautious on Fifth Third (FITB).
10/04/16
RAJA
10/04/16
DOWNGRADE
RAJA
Underperform
Wells Fargo downgraded to Underperform from Market Perform at Raymond James
Raymond James analyst David Long downgraded Wells Fargo to Underperform and reduced estimate saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook.
10/04/16
10/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Underperform from Market Perform at Raymond James with analyst David Long saying the fallout from the unauthorized account openings will result in continued under performance. The analyst said several additional investigations, lawsuits, and fines have been announced, resulting in a still cloudy outlook. 2. Kinder Morgan (KMI) downgraded to Hold from Buy at Stifel analyst Selman Akyol citing valuation. 3. GrubHub (GRUB) downgraded to Hold from Buy at Stifel with analyst John Egbert citing valuation. 4. Dr Pepper Snapple (DPS) downgraded to Hold from Buy at Evercore ISI with analyst Robert Ottenstein saying reports that Bai Brands is looking for a new owner are credible and could change investor's psychology on the stock and its Allied Brands business. 5. Dollar Tree (DLTR) downgraded to Neutral from Buy at Cleveland Research with the firm saying sales trends appear to have slowed further at Family Dollar as the company struggles with increased price competition, difficult comps, and strategy headwinds. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ALXN

Alexion

$126.23

2.65 (2.14%)

08:05
06/23/17
06/23
08:05
06/23/17
08:05
Hot Stocks
Alexion announces positive CHMP opinion for Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALGN

Align Technology

$149.69

0.27 (0.18%)

08:04
06/23/17
06/23
08:04
06/23/17
08:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

TRMK

Trustmark

$31.67

-0.53 (-1.65%)

08:04
06/23/17
06/23
08:04
06/23/17
08:04
Downgrade
Trustmark rating change  »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Hot Stocks
AVEO Oncology reports positive CHMP opinion for tivozanib as RCC treatment »

AVEO Oncolog announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$170.68

0.5 (0.29%)

, HUM

Humana

$237.00

0.79 (0.33%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Recommendations
Cigna, Humana, Aetna, WellCare, Anthem, Health Net, Centene, Molina Healthcare, UnitedHealth analyst commentary  »

Jefferies says healthcare…

CI

Cigna

$170.68

0.5 (0.29%)

HUM

Humana

$237.00

0.79 (0.33%)

AET

Aetna

$152.98

0.88 (0.58%)

WCG

WellCare

$183.60

6.06 (3.41%)

ANTM

Anthem

$193.36

1.29 (0.67%)

HNT

Health Net

CNC

Centene

$83.00

2.88 (3.59%)

MOH

Molina Healthcare

$71.31

1.58 (2.27%)

UNH

UnitedHealth

$186.50

1.58 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ZAYO

Zayo Group

$31.27

-0.54 (-1.70%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Hot Stocks
Zayo Group selected by global webscale company for wavelength solution »

A global webscale company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$47.18

0.48 (1.03%)

08:02
06/23/17
06/23
08:02
06/23/17
08:02
Hot Stocks
Williams-Sonoma to open expansive dual concept store in Seattle »

Williams Sonoma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRFT

Perficient

$17.55

0.15 (0.86%)

08:01
06/23/17
06/23
08:01
06/23/17
08:01
Hot Stocks
Perficient acquires Clarity Consulting in accretive deal »

Perficient announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

NSAT

Norsat

08:01
06/23/17
06/23
08:01
06/23/17
08:01
Hot Stocks
Norsat shareholders approve plan of arrangement with Hytera Communications »

Norsat announced that at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$1.30

-0.01 (-0.76%)

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Hot Stocks
Catabasis Pharmaceuticals to present results from MoveDMD trial at PPMD »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$7.80

0.29 (3.86%)

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Options
Pandora call buyer realizes 8% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BIIB

Biogen

$280.57

1.97 (0.71%)

, SSNLF

Samsung

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Hot Stocks
Biogen's IMRALDI granted positive opinion by CHMP »

The Committee for…

BIIB

Biogen

$280.57

1.97 (0.71%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

08:00
06/23/17
06/23
08:00
06/23/17
08:00
General news
N.Y. FX Outlook: The dollar looks likely to remain on a neutral footing »

N.Y. FX Outlook: The…

FIT

Fitbit

$5.09

0.1 (2.00%)

07:59
06/23/17
06/23
07:59
06/23/17
07:59
Recommendations
Fitbit analyst commentary  »

Fitbit reorganization of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

07:59
06/23/17
06/23
07:59
06/23/17
07:59
Technical Analysis
Technical View: Hain Celestial near 52-week low in pre-market, analyst actions »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MEI

Methode Electronics

$40.10

1.45 (3.75%)

07:54
06/23/17
06/23
07:54
06/23/17
07:54
Recommendations
Methode Electronics analyst commentary  »

Baird remains a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

, TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Periodicals
Foxconn's Gou still sees 50% chance of landing Toshiba chip unit, DigiTimes says »

Foxconn (HNHPF) Chairman…

HNHPF

Hon Hai Precision

TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

TOSBF

Toshiba, also use TOSYY

$2.88

-0.01 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$35.36

0.48 (1.38%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Hot Stocks
AstraZeneca announces positive CHMP opinion for Faslodex »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

V

Visa

$93.95

-0.59 (-0.62%)

07:52
06/23/17
06/23
07:52
06/23/17
07:52
Recommendations
Visa analyst commentary  »

Visa a good idea for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$19.88

0.38 (1.95%)

07:51
06/23/17
06/23
07:51
06/23/17
07:51
Technical Analysis
Technical View: Cara Therapeutics at new 52-week high in pre-market »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

KMX

CarMax

$62.50

2.76 (4.62%)

07:51
06/23/17
06/23
07:51
06/23/17
07:51
Recommendations
CarMax analyst commentary  »

CarMax weakness on sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 29

    Jun

  • 30

    Jun

07:50
06/23/17
06/23
07:50
06/23/17
07:50
General news
Treasury Market Outlook: bonds are mixed while stocks are mostly lower »

Treasury Market Outlook:…

ENTA

Enanta

$37.11

1.77 (5.01%)

, ABBV

AbbVie

$73.18

1.84 (2.58%)

07:49
06/23/17
06/23
07:49
06/23/17
07:49
Hot Stocks
Enanta announces AbbVie recieves CHMP positive opinion for MAVIRET »

Enanta Pharmaceuticals…

ENTA

Enanta

$37.11

1.77 (5.01%)

ABBV

AbbVie

$73.18

1.84 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OTIC

Otonomy

$17.75

0.25 (1.43%)

07:48
06/23/17
06/23
07:48
06/23/17
07:48
Recommendations
Otonomy analyst commentary  »

Otonomy trial has high…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$56.23

0.27 (0.48%)

07:45
06/23/17
06/23
07:45
06/23/17
07:45
Recommendations
Harley-Davidson analyst commentary  »

Harley-Davidson retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.